Nuvalent, Inc. (NUVL)
107.46
+2.51
(+2.39%)
USD |
NASDAQ |
May 27, 16:00
107.46
0.00 (0.00%)
After-Hours: 16:39
Nuvalent Cash from Investing (Quarterly) : -19.41M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | -36.46M |
| BioMarin Pharmaceutical, Inc. | 725.53M |
| Olema Pharmaceuticals, Inc. | 4.529M |
| Vera Therapeutics, Inc. | -137.82M |
| Tyra Biosciences, Inc. | -120.24M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -92.40M |
| Cash from Financing (Quarterly) | 9.801M |
| Free Cash Flow | -312.79M |
| Free Cash Flow Per Share (Quarterly) | -1.174 |
| Free Cash Flow to Equity (Quarterly) | -92.40M |
| Free Cash Flow to Firm (Quarterly) | -92.40M |
| Free Cash Flow Yield | -3.91% |